找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: MHC Class-I Loss and Cancer Immune Escape; Federico Garrido Book 2019 Springer Nature Switzerland AG 2019 tumor.immune escape.T lymphocyte

[復(fù)制鏈接]
樓主: 爆發(fā)
11#
發(fā)表于 2025-3-23 13:13:45 | 只看該作者
12#
發(fā)表于 2025-3-23 16:44:27 | 只看該作者
MHC/HLA Class I Loss in Cancer Cells,LA class-I phenotypes can be observed that are produced by different molecular mechanisms. Experimental and histological evidences are summarized indicating that at the early stages of tumour development there is an enormous variety of tumour clones with different MHC class I expression patterns. Th
13#
發(fā)表于 2025-3-23 21:23:14 | 只看該作者
HLA Class-I Expression and Cancer Immunotherapy,py? Are T lymphocytes responsible for tumour rejection and how these responses can be boosted? These questions are discussed in the context of the molecular mechanisms responsible for MHC/HLA class I alterations. If the metastatic tumour cells harbor “irreversible/hard” HLA lesions, they will escape
14#
發(fā)表于 2025-3-24 02:15:27 | 只看該作者
Book 2019“Antigen Presenting Molecules” and the “T Lymphocytes”. The former are known as the Major Histocompatibility Complex (MHC): the H-2 and the HLA molecules. The latter are a subgroup of white cells travelling all over our body which are capable to distinguish between “self and non self”...Readers will
15#
發(fā)表于 2025-3-24 04:37:46 | 只看該作者
Introduction,research have important implications for the new generation of cancer immunotherapy that boosts T cell responses. A historical perspective of major discoveries is presented in this chapter, with the names of the scientists that have made a significant contribution to the enormous progress made in the field of Tumour Immunology.
16#
發(fā)表于 2025-3-24 09:24:04 | 只看該作者
17#
發(fā)表于 2025-3-24 14:20:06 | 只看該作者
0065-2598 cape strategies used by cancer cells to avoid the immune response of the host. The main characters of this story are the “Antigen Presenting Molecules” and the “T Lymphocytes”. The former are known as the Major Histocompatibility Complex (MHC): the H-2 and the HLA molecules. The latter are a subgrou
18#
發(fā)表于 2025-3-24 18:27:57 | 只看該作者
MHC/HLA Class I Loss in Cancer Cells,the generation of different tumor cell clones with altered MHC class I phenotypes, which could be similar or different from the original tumor clone. The biological and immunological relevance of these observations is discussed. Finally, the interesting phenomenon of metastatic dormancy is analyzed
19#
發(fā)表于 2025-3-24 20:41:19 | 只看該作者
Book 2019 stimulating T lymphocytes to destroy tumor cells. However, the clinical response rate is not as high as expected. The molecular mechanisms responsible for MHC/HLA antigen loss play a crucial role in this resistance to immunotherapy. This immune escape mechanism will be discussed in different types
20#
發(fā)表于 2025-3-25 00:18:01 | 只看該作者
Federico Garridoden.. Eine ?hnliche Aufgabe zur Nachprüfung von Pers?nlichkeit und Sp?tschicksal stellte sich . in seinen Studien über eingeschriebene Prostituierte, die 1926 durch die Kata-mnesen . erg?nzt wurden ; . untersuchte den geisteskranken Strafgefangenen, . den Landstreicher in seinem Lebensgange.; auf de
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-25 01:31
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
买车| 英山县| 贡嘎县| 安宁市| 增城市| 新龙县| 昌乐县| 北流市| 开封市| 柳林县| 望谟县| 莆田市| 和龙市| 广宁县| 松溪县| 和硕县| 开远市| 高青县| 喀什市| 固始县| 商洛市| 青州市| 庆阳市| 虎林市| 营山县| 临汾市| 田阳县| 张家港市| 邹城市| 财经| 漠河县| 怀远县| 江安县| 增城市| 宜城市| 得荣县| 金湖县| 斗六市| 汶上县| 乐安县| 巫山县|